 | • レポートコード：GIR-2104Z14471 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、尿路がんのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。尿路がんの種類別市場規模（尿路上皮がん、扁平上皮がん、腺がん、その他）、用途別市場規模（病院、診療所、研究センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・尿路がんの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Spectrum Pharmaceuticals Boehringer Ingelheim、Bristol-Myers Squibb Company、Genzyme Corporation、F. Hoffmann-La Roche、Shionogi、Kyowa Hakko Kirin、Medical Enzymes、IkerChem、Amgen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：尿路上皮がん、扁平上皮がん、腺がん、その他 ・用途別分析2016年-2026年：病院、診療所、研究センター、その他 ・尿路がんの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・尿路がんのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・尿路がんのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・尿路がんの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・尿路がんの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Urinary Tract Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Urinary Tract Cancer size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Urinary Tract Cancer market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Urinary Tract Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Urothelial Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Research Centers
Others
Market segment by players, this report covers
Spectrum Pharmaceuticals Boehringer Ingelheim
Bristol-Myers Squibb Company
Genzyme Corporation
F. Hoffmann-La Roche
Shionogi
Kyowa Hakko Kirin
Medical Enzymes
IkerChem
Amgen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Urinary Tract Cancer
1.2 Classification of Urinary Tract Cancer by Type
1.2.1 Overview: Global Urinary Tract Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Urinary Tract Cancer Revenue Market Share by Type in 2020
1.2.3 Urothelial Carcinoma
1.2.4 Squamous Cell Carcinoma
1.2.5 Adenocarcinoma
1.2.6 Others
1.3 Global Urinary Tract Cancer Market by Application
1.3.1 Overview: Global Urinary Tract Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Global Urinary Tract Cancer Market Size & Forecast
1.5 Global Urinary Tract Cancer Market Size and Forecast by Region
1.5.1 Global Urinary Tract Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Urinary Tract Cancer Market Size by Region, (2016-2021)
1.5.3 North America Urinary Tract Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Urinary Tract Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Urinary Tract Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Urinary Tract Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Urinary Tract Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Urinary Tract Cancer Market Drivers
1.6.2 Urinary Tract Cancer Market Restraints
1.6.3 Urinary Tract Cancer Trends Analysis
2 Company Profiles
2.1 Spectrum Pharmaceuticals Boehringer Ingelheim
2.1.1 Spectrum Pharmaceuticals Boehringer Ingelheim Details
2.1.2 Spectrum Pharmaceuticals Boehringer Ingelheim Major Business
2.1.3 Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Product and Solutions
2.1.4 Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Spectrum Pharmaceuticals Boehringer Ingelheim Recent Developments and Future Plans
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Urinary Tract Cancer Product and Solutions
2.2.4 Bristol-Myers Squibb Company Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.3 Genzyme Corporation
2.3.1 Genzyme Corporation Details
2.3.2 Genzyme Corporation Major Business
2.3.3 Genzyme Corporation Urinary Tract Cancer Product and Solutions
2.3.4 Genzyme Corporation Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Genzyme Corporation Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Urinary Tract Cancer Product and Solutions
2.4.4 F. Hoffmann-La Roche Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.5 Shionogi
2.5.1 Shionogi Details
2.5.2 Shionogi Major Business
2.5.3 Shionogi Urinary Tract Cancer Product and Solutions
2.5.4 Shionogi Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Shionogi Recent Developments and Future Plans
2.6 Kyowa Hakko Kirin
2.6.1 Kyowa Hakko Kirin Details
2.6.2 Kyowa Hakko Kirin Major Business
2.6.3 Kyowa Hakko Kirin Urinary Tract Cancer Product and Solutions
2.6.4 Kyowa Hakko Kirin Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Kyowa Hakko Kirin Recent Developments and Future Plans
2.7 Medical Enzymes
2.7.1 Medical Enzymes Details
2.7.2 Medical Enzymes Major Business
2.7.3 Medical Enzymes Urinary Tract Cancer Product and Solutions
2.7.4 Medical Enzymes Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Medical Enzymes Recent Developments and Future Plans
2.8 IkerChem
2.8.1 IkerChem Details
2.8.2 IkerChem Major Business
2.8.3 IkerChem Urinary Tract Cancer Product and Solutions
2.8.4 IkerChem Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 IkerChem Recent Developments and Future Plans
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Urinary Tract Cancer Product and Solutions
2.9.4 Amgen Urinary Tract Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Amgen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Urinary Tract Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Urinary Tract Cancer Players Market Share
3.2.2 Top 10 Urinary Tract Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Urinary Tract Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Urinary Tract Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Urinary Tract Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Urinary Tract Cancer Revenue Market Share by Application (2016-2021)
5.2 Urinary Tract Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Urinary Tract Cancer Revenue by Type (2016-2026)
6.2 North America Urinary Tract Cancer Revenue by Application (2016-2026)
6.3 North America Urinary Tract Cancer Market Size by Country
6.3.1 North America Urinary Tract Cancer Revenue by Country (2016-2026)
6.3.2 United States Urinary Tract Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Urinary Tract Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Urinary Tract Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Urinary Tract Cancer Revenue by Type (2016-2026)
7.2 Europe Urinary Tract Cancer Revenue by Application (2016-2026)
7.3 Europe Urinary Tract Cancer Market Size by Country
7.3.1 Europe Urinary Tract Cancer Revenue by Country (2016-2026)
7.3.2 Germany Urinary Tract Cancer Market Size and Forecast (2016-2026)
7.3.3 France Urinary Tract Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Urinary Tract Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Urinary Tract Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Urinary Tract Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Urinary Tract Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Urinary Tract Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Urinary Tract Cancer Market Size by Region
8.3.1 Asia-Pacific Urinary Tract Cancer Revenue by Region (2016-2026)
8.3.2 China Urinary Tract Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Urinary Tract Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Urinary Tract Cancer Market Size and Forecast (2016-2026)
8.3.5 India Urinary Tract Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Urinary Tract Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Urinary Tract Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Urinary Tract Cancer Revenue by Type (2016-2026)
9.2 South America Urinary Tract Cancer Revenue by Application (2016-2026)
9.3 South America Urinary Tract Cancer Market Size by Country
9.3.1 South America Urinary Tract Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Urinary Tract Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Urinary Tract Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Urinary Tract Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Urinary Tract Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Urinary Tract Cancer Market Size by Country
10.3.1 Middle East & Africa Urinary Tract Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Urinary Tract Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Urinary Tract Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Urinary Tract Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Urinary Tract Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Urinary Tract Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Urinary Tract Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Urinary Tract Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Urinary Tract Cancer Revenue Market Share by Region (2021-2026)
Table 6. Spectrum Pharmaceuticals Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 7. Spectrum Pharmaceuticals Boehringer Ingelheim Major Business
Table 8. Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Product and Solutions
Table 9. Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 11. Bristol-Myers Squibb Company Major Business
Table 12. Bristol-Myers Squibb Company Urinary Tract Cancer Product and Solutions
Table 13. Bristol-Myers Squibb Company Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Genzyme Corporation Corporate Information, Head Office, and Major Competitors
Table 15. Genzyme Corporation Major Business
Table 16. Genzyme Corporation Urinary Tract Cancer Product and Solutions
Table 17. Genzyme Corporation Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 19. F. Hoffmann-La Roche Major Business
Table 20. F. Hoffmann-La Roche Urinary Tract Cancer Product and Solutions
Table 21. F. Hoffmann-La Roche Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Shionogi Corporate Information, Head Office, and Major Competitors
Table 23. Shionogi Major Business
Table 24. Shionogi Urinary Tract Cancer Product and Solutions
Table 25. Shionogi Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Kyowa Hakko Kirin Corporate Information, Head Office, and Major Competitors
Table 27. Kyowa Hakko Kirin Major Business
Table 28. Kyowa Hakko Kirin Urinary Tract Cancer Product and Solutions
Table 29. Kyowa Hakko Kirin Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Medical Enzymes Corporate Information, Head Office, and Major Competitors
Table 31. Medical Enzymes Major Business
Table 32. Medical Enzymes Urinary Tract Cancer Product and Solutions
Table 33. Medical Enzymes Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. IkerChem Corporate Information, Head Office, and Major Competitors
Table 35. IkerChem Major Business
Table 36. IkerChem Urinary Tract Cancer Product and Solutions
Table 37. IkerChem Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Amgen Corporate Information, Head Office, and Major Competitors
Table 39. Amgen Major Business
Table 40. Amgen Urinary Tract Cancer Product and Solutions
Table 41. Amgen Urinary Tract Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Urinary Tract Cancer Revenue (USD Million) by Players (2019-2021)
Table 43. Global Urinary Tract Cancer Revenue Share by Players (2019-2021)
Table 44. Breakdown of Urinary Tract Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Urinary Tract Cancer Players Head Office, Products and Services Provided
Table 46. Urinary Tract Cancer Mergers & Acquisitions in the Past Five Years
Table 47. Urinary Tract Cancer New Entrants and Expansion Plans
Table 48. Global Urinary Tract Cancer Revenue (USD Million) by Type (2016-2021)
Table 49. Global Urinary Tract Cancer Revenue Share by Type (2016-2021)
Table 50. Global Urinary Tract Cancer Revenue Forecast by Type (2021-2026)
Table 51. Global Urinary Tract Cancer Revenue by Application (2016-2021)
Table 52. Global Urinary Tract Cancer Revenue Forecast by Application (2021-2026)
Table 53. North America Urinary Tract Cancer Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Urinary Tract Cancer Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Urinary Tract Cancer Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Urinary Tract Cancer Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Urinary Tract Cancer Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Urinary Tract Cancer Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Urinary Tract Cancer Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Urinary Tract Cancer Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Urinary Tract Cancer Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Urinary Tract Cancer Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Urinary Tract Cancer Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Urinary Tract Cancer Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Urinary Tract Cancer Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Urinary Tract Cancer Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Urinary Tract Cancer Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Urinary Tract Cancer Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Urinary Tract Cancer Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Urinary Tract Cancer Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Urinary Tract Cancer Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Urinary Tract Cancer Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Urinary Tract Cancer Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Urinary Tract Cancer Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Urinary Tract Cancer Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Urinary Tract Cancer Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Urinary Tract Cancer Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Urinary Tract Cancer Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Urinary Tract Cancer Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Urinary Tract Cancer Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Urinary Tract Cancer Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Urinary Tract Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Urinary Tract Cancer Picture
Figure 2. Global Urinary Tract Cancer Revenue Market Share by Type in 2020
Figure 3. Urothelial Carcinoma
Figure 4. Squamous Cell Carcinoma
Figure 5. Adenocarcinoma
Figure 6. Others
Figure 7. Urinary Tract Cancer Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Research Centers Picture
Figure 11. Others Picture
Figure 12. Global Urinary Tract Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Urinary Tract Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Urinary Tract Cancer Revenue Market Share by Region (2016-2026)
Figure 15. Global Urinary Tract Cancer Revenue Market Share by Region in 2020
Figure 16. North America Urinary Tract Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Urinary Tract Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Urinary Tract Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Urinary Tract Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Urinary Tract Cancer Market Drivers
Figure 21. Urinary Tract Cancer Market Restraints
Figure 22. Urinary Tract Cancer Market Trends
Figure 23. Spectrum Pharmaceuticals Boehringer Ingelheim Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 25. Genzyme Corporation Recent Developments and Future Plans
Figure 26. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 27. Shionogi Recent Developments and Future Plans
Figure 28. Kyowa Hakko Kirin Recent Developments and Future Plans
Figure 29. Medical Enzymes Recent Developments and Future Plans
Figure 30. IkerChem Recent Developments and Future Plans
Figure 31. Amgen Recent Developments and Future Plans
Figure 33. Global Urinary Tract Cancer Revenue Share by Players in 2020
Figure 34. Urinary Tract Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Urinary Tract Cancer Revenue Market Share in 2020
Figure 36. Global Top 10 Players Urinary Tract Cancer Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Urinary Tract Cancer Revenue Share by Type in 2020
Figure 39. Global Urinary Tract Cancer Market Share Forecast by Type (2021-2026)
Figure 40. Global Urinary Tract Cancer Revenue Share by Application in 2020
Figure 41. Global Urinary Tract Cancer Market Share Forecast by Application (2021-2026)
Figure 42. North America Urinary Tract Cancer Sales Market Share by Type (2016-2026)
Figure 43. North America Urinary Tract Cancer Sales Market Share by Application (2016-2026)
Figure 44. North America Urinary Tract Cancer Revenue Market Share by Country (2016-2026)
Figure 45. United States Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Urinary Tract Cancer Sales Market Share by Type (2016-2026)
Figure 49. Europe Urinary Tract Cancer Sales Market Share by Application (2016-2026)
Figure 50. Europe Urinary Tract Cancer Revenue Market Share by Country (2016-2026)
Figure 51. Germany Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Urinary Tract Cancer Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Urinary Tract Cancer Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Urinary Tract Cancer Revenue Market Share by Region (2016-2026)
Figure 59. China Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Urinary Tract Cancer Sales Market Share by Type (2016-2026)
Figure 66. South America Urinary Tract Cancer Sales Market Share by Application (2016-2026)
Figure 67. South America Urinary Tract Cancer Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Urinary Tract Cancer Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Urinary Tract Cancer Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Urinary Tract Cancer Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Urinary Tract Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…- 世界の尿路感染症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Urinary Tract Infection Therapeutics Market The global Urinary Tract Infection Therapeutics market size is projected to reach US$ 81750 million by 2026, from US$ 71130 million in 2019, at a CAGR of 2.0% during 2021-2026. With industry-standard accuracy in analysi…
- 世界の院内感染性尿路感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital-acquired Urinary Tract Infection Testing Market The global Hospital-acquired Urinary Tract Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard …
- 世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital Acquired Urinary Tract Infection Market The global Hospital Acquired Urinary Tract Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in anal…
- 世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital Acquired Urinary Tract Infection Market The global Hospital Acquired Urinary Tract Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in anal…